TrialReader

Changes in Lab and Ultrasonography After Endoscopic Varisceal Treatment

NCT03269786 — Unknown, 100 participants, Assiut University
ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Laoboratory and Ultrasonographic Changes After Endoscopic Varisceal Treatment

RegistryNCT03269786
StatusUnknown
Study typeObservational
Enrollment100 (Estimated)
SponsorAssiut University (Other)
ConditionsLiver Cirrhosis
InterventionsLiver function tests (ALT,AST,ALBUMIN,BILIRUBIN,INR,PC,CBC), biannual ultrasonography (Diagnostic test, device)
Datesstart 2018-11-01 (estimated), primary completion 2019-11-01 (estimated), completion 2019-11-01 (estimated), first posted 2017-09-01, last updated 2018-10-09
Locations1 site in Egypt

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Liver Cirrhosis All trials of Liver function tests (ALT,AST,ALBUMIN,BILIRUBIN,INR,PC,CBC) All trials of biannual ultrasonography

-Summary

laboratory and ultrasongraphicc changes after endoscopical varices treatment

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
cirrhotic patients with esophagel variscesDiagnostic Test: Liver function tests (ALT,AST,ALBUMIN,BILIRUBIN,INR,PC,CBC); Device: biannual ultrasonographyEndoscopic band ligation or injection scelerotheraby will be done for all patients
  • Liver function tests (ALT,AST,ALBUMIN,BILIRUBIN,INR,PC,CBC) (Diagnostic test): Liver function tests will be assessed after endoscopic varisceal treatment for 6 monthes
  • biannual ultrasonography (Device): portal vein diameter , portal vein velocity and flow direction, volume flow in portal vein , congetive index, spleen size.will be assessed after endoscopic varisceal treatment by using biannual ultrasonography for 6 monthes

+Outcome measures

Primary outcomes

  • Changes in liver function tests [6 months]: Liver function tests (ALT, AST, bilirubin,Albumin,Cbc,Prothrombin time,INR ) level (expected to be lower after endoscopic varisceal treatment (ex
  • Ultrasonographic changes [6 months]: { portal vein diameter , portal vein velocity and flow direction, volume flow in portal vein , congetive index, spleen size.(expected to be chnged after endoscopic varisceal treatment

+Eligibility

Sex: All, ages: 18 Years to 60 Years

Inclusion Criteria:

* patients with liver cirrhosis and portal hyprtension with esophagel varisces

Exclusion Criteria:

* 1\. Patients with heart failure or renal failure 2. patients with COPD 3. Patients with hepato cellular carcinoma and portal vein thrombosis 4. Pregnant

+Locations (1)

FacilityCityCountryStatus
Assiut UniversityAsyutEgypt

My Notes